| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.38 | 0.04 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.35 | 0.05 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.31 | 0.08 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 8e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.19 | 0.3 |